The Pharmacological Treatment of Pediatric Vertigo

Area of Science:

• Pediatrics
• Neurology
• Otolaryngology

Background:

• Pediatric vertigo presents unique challenges due to limited research and inconsistent treatment protocols.
• Conditions like Meniere's disease, vestibular neuritis, and benign paroxysmal positional vertigo (BPPV) affect children, with varying severity.
• Current drug management strategies are often age-dependent and lack robust evidence.

Purpose of the Study:

• To review existing evidence on drug use for vertigo and dizziness in children.
• To identify gaps in knowledge and inform the development of new clinical trials.
• To emphasize the critical need for international guidelines in pediatric vertigo management.

Main Methods:

• Systematic review of literature concerning pharmacotherapy for pediatric vertigo.
• Analysis of studies addressing Meniere's disease, migraine equivalents, vestibular neuritis, BPPV, persistent postural-perceptual dizziness (PPPD), and motion sickness in children.
• Evaluation of drug efficacy and safety based on available pediatric data.

Main Results:

• Evidence for drug efficacy in treating pediatric vertigo is limited and often extrapolated from adult data.
• Several medications are proposed, but their use requires careful consideration of the child's age and specific condition.
• Significant heterogeneity exists in treatment approaches due to the lack of established guidelines.

Conclusions:

• There is an urgent need for high-quality clinical trials to establish evidence-based treatment guidelines for pediatric vertigo.
• Standardized diagnostic and therapeutic approaches are essential for improving patient outcomes.
• International collaboration is crucial for developing comprehensive guidelines for managing vertigo in children.